113 related articles for article (PubMed ID: 31074835)
21. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
[TBL] [Abstract][Full Text] [Related]
22. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.
Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Hayfron-Benjamin A; Abdul L; Simpore J; Mayaud P
BMC Womens Health; 2017 Sep; 17(1):86. PubMed ID: 28950841
[TBL] [Abstract][Full Text] [Related]
23. Acceptability of self-collected vaginal samples for HPV testing in an urban and rural population of Madagascar.
Broquet C; Triboullier D; Untiet S; Schafer S; Petignat P; Vassilakos P
Afr Health Sci; 2015 Sep; 15(3):755-61. PubMed ID: 26957962
[TBL] [Abstract][Full Text] [Related]
24. Community-based self-collected human papillomavirus screening in rural Zimbabwe.
Fitzpatrick MB; El-Khatib Z; Katzenstein D; Pinsky BA; Chirenje ZM; McCarty K
BMC Public Health; 2019 May; 19(Suppl 1):603. PubMed ID: 31138174
[TBL] [Abstract][Full Text] [Related]
25. hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing.
Fitzpatrick MB; Dube Mandishora RS; Katzenstein DA; McCarty K; Weber J; Sahoo MK; Manasa J; Chirenje ZM; Pinsky BA
Int J Infect Dis; 2019 May; 82():21-29. PubMed ID: 30807869
[TBL] [Abstract][Full Text] [Related]
26. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
27. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
[TBL] [Abstract][Full Text] [Related]
28. Assessing Acceptability of Self-Sampling Kits, Prevalence, and Risk Factors for Human Papillomavirus Infection in American Indian Women.
Winer RL; Gonzales AA; Noonan CJ; Cherne SL; Buchwald DS;
J Community Health; 2016 Oct; 41(5):1049-61. PubMed ID: 27048284
[TBL] [Abstract][Full Text] [Related]
29. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
[TBL] [Abstract][Full Text] [Related]
30. Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
Sy AU; Hernandez BY; Tareg A; Reichhardt M; Buenconsejo-Lum L
Cancer Epidemiol; 2017 Oct; 50(Pt B):283-288. PubMed ID: 29120838
[TBL] [Abstract][Full Text] [Related]
31. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
[TBL] [Abstract][Full Text] [Related]
33. Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study.
Aitken CA; van Agt HME; Siebers AG; van Kemenade FJ; Niesters HGM; Melchers WJG; Vedder JEM; Schuurman R; van den Brule AJC; van der Linden HC; Hinrichs JWJ; Molijn A; Hoogduin KJ; van Hemel BM; de Kok IMCM
BMC Med; 2019 Dec; 17(1):228. PubMed ID: 31829241
[TBL] [Abstract][Full Text] [Related]
34. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
Nishino HT; Tambouret RH; Wilbur DC
Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
[TBL] [Abstract][Full Text] [Related]
35. [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum].
Göktuğ Kadıoğlu B; Çınar Tanrıverdi E; Alay H; Uçar M
Mikrobiyol Bul; 2018 Oct; 52(4):367-375. PubMed ID: 30522422
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital.
Thistle P; Parpia R; Pain D; Lee H; Manasa J; Schnipper LE
JCO Glob Oncol; 2020 Aug; 6():1276-1281. PubMed ID: 32783640
[TBL] [Abstract][Full Text] [Related]
37. Feasibility and Accuracy of Menstrual Blood Testing for High-risk Human Papillomavirus Detection With Capture Sequencing.
Zhang J; Tian X; Chen Y; Huang S; Cui Z; Tian R; Zeng Z; Liang W; Gong Q; Shang R; Hu Z; Cao C
JAMA Netw Open; 2021 Dec; 4(12):e2140644. PubMed ID: 34940863
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the feasibility of utilizing Gynocular-triage-to-diagnose application with VIA (Visual inspection with Acetic acid) in community cervical cancer screening programs in rural Mysore, India.
Srinivas V; Nishimura HM; Jayakrishna P; Krupp K; Madhivanan P; Madhunapantula SV
Indian J Cancer; 2021; 58(3):409-416. PubMed ID: 33402563
[TBL] [Abstract][Full Text] [Related]
39. Community-based Mobile Cervical Cancer Screening Program in Rural India: Successes and Challenges for Implementation.
Srinivas V; Herbst De Cortina S; Nishimura H; Krupp K; Jayakrishna P; Ravi K; Khan A; Madhunapantula SV; Madhivanan P
Asian Pac J Cancer Prev; 2021 May; 22(5):1393-1400. PubMed ID: 34048166
[TBL] [Abstract][Full Text] [Related]
40. Systems-level barriers to treatment in a cervical cancer prevention program in Kenya: Several observational studies.
Page CM; Ibrahim S; Park LP; Huchko MJ
PLoS One; 2020; 15(7):e0235264. PubMed ID: 32658921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
